These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5402805)

  • 1. [Effects of a regulator of the sympathetic system in thyroid pathology].
    Mornex R; Fitoussi R; Pousset G; Perrin N
    Rev Lyon Med; 1969 Oct; 18(15):591-8. PubMed ID: 5402805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of the adrenergic receptors. II. Use of their inhibitors in endocrinology; indications and results].
    Mornex R
    Ann Endocrinol (Paris); 1967; 28(4):557-73. PubMed ID: 6081825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toward a possible new treatment of diabetes mellitus].
    Laforet J
    Rev Iber Endocrinol; 1965; 12(69):195-201. PubMed ID: 5847375
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of sympatholytin on the development of the hemodynamic effects of thyroid hormones].
    Ester KM; Kandror VI
    Biull Eksp Biol Med; 1967 Jun; 63(6):30-3. PubMed ID: 5622606
    [No Abstract]   [Full Text] [Related]  

  • 5. [New data on the drug therapy of angina pectoris].
    Urbaszek W
    Z Gesamte Inn Med; 1966 Nov; 21(21):641-9. PubMed ID: 5994727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of thyroid gland tumors, especially the hyperthyroidism in diabetics].
    Dempe A
    Z Arztl Fortbild (Jena); 1966 May; 60(9):547-9. PubMed ID: 5988059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induced adrenalinuria test in thyroid diseases (apropos of 140 tests in 116 subjects)].
    Mornex R; Peyrin L; Gibaud A
    Rev Fr Endocrinol Clin; 1967; 8(2):113-23. PubMed ID: 6050710
    [No Abstract]   [Full Text] [Related]  

  • 8. [The place of new sympatholytics in treatment of hyperthyroidism and hypothyroidism].
    Bricaire H; Joly J
    Therapeutique; 1969 Jan; 45(1):61-2. PubMed ID: 5792154
    [No Abstract]   [Full Text] [Related]  

  • 9. [The beta-blocking drugs in hyperthyroidism. 2. Effects on metabolic and biochemical changes].
    De Gregori ME; Bellotti G; Ghidini O; Giardina F; Mantovanelli S
    Minerva Med; 1971 Mar; 62(26):1374-82. PubMed ID: 5554155
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with thyrotoxicosis with sympatholytic drugs.
    Bell RL
    J Tenn Med Assoc; 1976 Mar; 69(3):200. PubMed ID: 1256053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of an antiadrenergic drug (OP'DDD) in the treatment of various diabetes].
    Legrand JC; Klotz HP; Chimènes H
    Diabete; 1969; 17(3):220-9. PubMed ID: 5360799
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy with sympatholytics].
    Schweitzer P
    Lek Veda Zahr; 1967 Dec; 12():225-31. PubMed ID: 4874499
    [No Abstract]   [Full Text] [Related]  

  • 13. The assessment and management of hyperthyroidism.
    Waldstein SS
    Otolaryngol Clin North Am; 1980 Feb; 13(1):13-27. PubMed ID: 6154274
    [No Abstract]   [Full Text] [Related]  

  • 14. [A beta receptor blocking agent in heart therapy].
    Schmidt-Voigt J
    Med Welt; 1966 Jan; 1():23-6. PubMed ID: 5942360
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blockade of beta receptors in clinical pharmacology and therapy].
    Gersmeyer EF; Spitzbarth H
    Med Welt; 1967 Apr; 13():764-80. PubMed ID: 5584453
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: The endogenous catabolic traumatic triad syndrome.
    DiNicola AF
    N Z Med J; 1975 Jul; 82(543):27-8. PubMed ID: 1057756
    [No Abstract]   [Full Text] [Related]  

  • 17. Some recently introduced drugs.
    Launchbury AP
    Prog Med Chem; 1970; 7(1):1-67. PubMed ID: 4250600
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on drugs used to treat endocrine diseases in small animals.
    Behrend EN
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1087-105, vii. PubMed ID: 16984828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of an antiadrenal drug (O.P.'D.D.D.) in treatment of various diabetic states].
    Klotz HP; Chimènes H; Legrand JC
    Diabete; 1968; 16(3):220-9. PubMed ID: 5760503
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid-blocking activity of chlorpropamide in a diabetic patient with hyperthyroidism.
    Tsou JY; Kotler M; Lavine RL
    Arch Intern Med; 1981 Apr; 141(5):690-1. PubMed ID: 7224756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.